| Nov 17 |
The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
|
| Nov 15 |
Inhibrx Biosciences GAAP EPS of -$2.84
|
| Nov 14 |
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
|
| Nov 5 |
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique Platform
|
| Nov 4 |
Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
|
| Sep 13 |
Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)
|
| Sep 3 |
Around $2M Bet On Franklin Resources? Check Out These 4 Stocks Executives Are Buying
|
| Aug 27 |
Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying
|
| Aug 23 |
Inhibrx gains after insider purchases from CEO
|
| Aug 14 |
Inhibrx Biosciences, Inc. GAAP EPS of $125.40, revenue of $100M
|
